GenFleet Therapeutics (Shanghai) (HKG:2595) is proposing to buy back up to HK$350 million Hong Kong-listed shares, according to a Monday Hong Kong bourse filing.
The biopharmaceutical company will repurchase the shares from the open market from time to time.